| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Margin | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — | — | — | — | — | — | — |
| Current Ratio | 0.05 | 0.15 | 18.69 | 12.51 | 13.05 | 6.18 | 3.01 | 6.75 | 4.74 | 8.69 | 7.20 | 0.43 |
| Quick Ratio | 0.05 | 0.15 | 18.69 | 12.51 | 13.05 | 6.18 | 3.01 | 6.75 | 4.74 | 8.69 | 7.20 | 0.43 |
| Debt / Equity | — | — | — | — | — | — | — | — | — | — | — | — |
| ROE | 120.45% | 1734.41% | -74.17% | -46.25% | -33.94% | -84.54% | -221.94% | -81.27% | -165.47% | -84.81% | -97.17% | 73.85% |
| ROA | 55.30% | -6670.82% | -70.22% | -42.05% | -30.91% | -70.51% | -146.74% | -68.60% | -123.59% | -71.79% | -80.34% | -20.44% |
| Asset Turnover | — | — | — | — | — | — | — | — | — | — | — | — |
| Book Value / Share | 0.55 | -0.25 | 4.05 | 7.28 | 12.19 | 10.66 | — | — | — | — | — | — |
Check-Cap Ltd. is a clinical-stage medical diagnostics company based in Israel, specializing in the development of innovative capsule-based screening technology for colorectal cancer detection. Founded in 2004, the company focuses on its proprietary C-Scan system, which includes an ingestible capsule that uses ultra-low-dose X-rays to non-invasively scan the inner lining of the colon for precancerous polyps and structural abnormalities. This capsule-based approach aims to provide patient-friendly, preparation-free colorectal screening to increase adherence and enable early intervention. The system comprises the C-Scan capsule, a disposable tracking device attached externally to the patient, and analytic software for data processing and report generation. Check-Cap's technology represents a significant advancement in non-invasive cancer diagnostics, aligning with the broader healthcare sector's focus on early detection and preventive medicine.